Working as an outsourcing partner, and with a long-standing tradition of quality and service, Paragon expands the capabilities of pharmaceutical companies, biotechnology companies and academic laboratories involved in identifying, developing and producing monoclonal antibodies, therapeutic proteins, disease biomarkers, vaccines and reagents for diagnostics.
Responsibility, duty, passion for science, overall optimism about the future, and our collective need to contribute is what makes Paragon successful among its peers. Furthermore, it is our recognition of the need for better public health—as scientists and engineers—that gets us motivated and excited about the work that we perform.
Guided by our mission to provide exceptional quality, scientific excellence and superior customer service, Paragon is committed to:
Forging long-lasting partnerships and working relationships
Honoring delivery schedules
Enhancing our client’s ROI
Paragon’s focus is the development and manufacturing of biopharmaceutical protein drugs. As a contract development and manufacturing organization (CDMO), Paragon is positioned to capitalize on industry trends—including consolidation in the pharmaceutical industry, all-encompassing “Programmatic Outsourcing”, and the looming imperative that is National Preparedness.
With 25 years in the business, Paragon’s scientists, engineers, quality systems personnel and project managers have many years of experience working with biologics—from research and process development services to GMP manufacturing for clinical trials and eventual commercial launch.
As a provider of contract research and manufacturing services for Phase I /II clinical trials, Paragon is Good Manufacturing Practices (GMP) compliant and provides batch records, quality control analysis, and certificates of analysis.